Haemodynamic implications of mitral regurgitation in heart failure with preserved ejection fraction

31 August 2019 (12:40 - 13:30)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Maria Amalia Tamargo Delpon

University Hospital of Salamanca, Salamanca (Spain)

6 More presentations in this session

Presentation thumbnail

Heart failure with mid-range (HFmrEF) or recovered (HFrecEF) ejection fraction: differential determinants of transition

Doctor A. Mortara (Monza, IT)

Abstract Slides

Presentation thumbnail

A single factor related to left atrial pressure overload is useful for prognosis in elderly patients with heart failure with preserved ejection fraction: PURSUIT HFpEF study

Doctor S. Hoshida (Yao, JP)

Abstract Slides

Presentation thumbnail

Inhibitors of the renin-angiotensin system in diabetic patients with heart failure with preserved ejection fraction treatment: impact of m235t polymorphism of angiotensinogen

Doctor O. Medentseva (Kharkiv, UA)

Abstract Slides

Presentation thumbnail

Impact of impaired right ventricular strain on the prognosis of HFpEF.

Doctor S. Lejeune (Brussels, BE)

Abstract Slides

Presentation thumbnail

Incremental value of left atrial strain in predicting atrial fibrillation in heart failure with preserved ejection fraction

Doctor E. Jasic-Szpak (Wroclaw, PL)

Abstract Slides

Access the full session

Session thumbnail

Novelties in pathophysiology of heart failure with preserved ejection fraction

The Event

ESC Congress 2019

31 August 2019 12:40 CET

You may be interested in

Congress Session

Clinical phenotypes of heart failure with preserved ejection fraction

Webinar

Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

Webinar

Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources